• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NUMED, INC. NUCLEUS AORTIC 20 MM; BALLOON AORTIC VALVULOPLASTY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NUMED, INC. NUCLEUS AORTIC 20 MM; BALLOON AORTIC VALVULOPLASTY Back to Search Results
Catalog Number PVN230
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Tachycardia (2095); Dizziness (2194); Rupture (2208); Heart Block (4444); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Event Description
Medtronic received information that following implant of this transcatheter bioprosthetic core valve there was moderate aortic regurgitation (ar).A balloon valvuloplasty was performed utilizing a non-medtronic balloon (numed canada inc.Nucleus aortic 20 mm reference number: pvn230 lot: y-3357), however post-valvuloplasty a ventricular septal rupture was documented on transesophageal echocardiogram (tee).The patient was intubated and a second core valve was successfully implanted which rectified the ar from moderate to mild.The ventricular septal rupture had subsequently reduced in size with no further sign of bleeding.Post-procedure (same day) the patient developed a left bundle branch block (lbbb).One day post-implant, complete heart block (chb) was noted when the patient temporary pacing rate was slowed.Also noted was occasional runs of non-sustained ventricular tachycardia, this caused some dizziness and palpitations which was treated with medication.The patient had a pacemaker successfully implanted six days post? implant due to the chb.No additional adverse patient effects were reported.(b)(4) this report reflects information received by fda in the form of a notification per 803.22 (b)(2).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NUCLEUS AORTIC 20 MM
Type of Device
BALLOON AORTIC VALVULOPLASTY
Manufacturer (Section D)
NUMED, INC.
MDR Report Key17523741
MDR Text Key321150965
Report NumberMW5130688
Device Sequence Number1
Product Code OZT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 09/09/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/12/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Catalogue NumberPVN230
Device Lot NumberY-3357
Patient Sequence Number1
-
-